Macular Degeneration Clinical Trials
Macular Degeneration Research
The most current information for macular degeneration studies is easy to access.The website www.ClinicalTrials.gov is a registry of federally and privately supported studies conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's: purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals. Just type in "macular degeneration" in the search field and a list of all the studies in 157 countries will come up. Currently there are 185 studies seeking new volunteers. Help Finding Macular Degeneration StudiesIf you would like to see if there are macular degeneration clinical trials in your city state or country fill out this form and I will perform a search for you on the U. S. National Institute of Health Website. Macular Degeneration StudiesSearch by Country, State or CityYou can limit the list geographically by adding your city or state. For example, in the search field you would type in:"macular degeneration Chicago" or "macular degeneration Illinois." Then hit "Hide studies that are not seeking new volunteers."
Search by Type of Macular Degeneration
You may also search new treatment for macular degeneration by the type of retinal disease you have. For instance you can enter
"wet macular degeneration"
and this way you only get clinical trials pertaining to wet macular degeneration.
For more information on wet macular degeneration clinical trials click here:
Wet Macular Degneration Clinical Trials
For a listing of dry macular degeneration studies click here:
Dry Macular Degeneration Clinical Trials
Search by Macular Degeneration Treatment
Searching macular degeneration clinical trials by treatment is also an option. Some of your searches could be: "Macular degeneration lutein" "Macular degeneration avastin"
"Macular degeneration omega 3" "Macular degeneration antioxidants"
Try it now by clicking on the link below:
Clinical Trials
Clinical Trial PhasesClinical trials are categorized by phases. Their are four phases with Phase I clinical trials testing mostly for safety and toxicity.You will find the phase listed in the Purpose section of the clinical trials in a box with these labels - Condition, Intervention and Phase. If you are considering a clinical trial it is a good idea to know about the different phases and what phase the clinical trial is in before you agree to participate. Click here to read a detailed description: Clinical Trial Phases Lucentis vs Avastin Clinical Trial
Macular degeneration research is a big focus at Emory Healthcare in Atlanta. Currently Emory Eye Center is the lead center among 47 other eye institutions who are recruiting individuals with wet macular degeneration. The study will compare the two drugs that are made by the same pharmaceutical company,
Lucentis
and it's less expensive "cousin",
Avastin.
To find out if there is a study center near you click on this link:
Comparison of ARMD Treatment: Lucentis-Avastin Trial
Clinical Trial for Low Vision RehabNot all clinical trials are focused on treatment. Studies can also be looking at quality of life issues. For instance in Chicago currently there is a study in which the purpose is to measure the effectiveness of a newly designed reading rehabilitation program for patients with dry macular disease. Patients with wet macular degeneration are excluded from this trial. If you would like to read about this study click here: Reading RehabilitationOmega 3 Research
Omega 3 research supports the intake of omega 3's for healthy eyes and a healthy macula.
One study is called the "Dietary Omega-3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration: A Systematic Review and Meta-analysis." The authors of this study found that high dietary intake of fish oils was associated with a 38% reduction in the risk of late macular degeneration. To learn more about how fish oil benefits the macula click here: AREDS VitaminsThe Age Related Eye Disease Study was a major clinical trial sponsored by the National Institute of Health. Recruitment began in September 1990 and the first results were published in a press release in 2001.The results stated that the AREDS "found that taking high levels of antioxidants and zinc can reduce the risk of developing advanced age related macular degeneration by about 25%." NIH News Release Friday, October 12, 2001 To learn more about this study click here: AREDS Vitamins Age Related Eye Disease Study 2 (AREDS 2)This is a multi-center randomized trial of approximately 4,200 participants. One of the objectives of this trial is to "study the effects of high supplemental doses of the dietary xanthophylls (lutein and zeaxanthin) and omega -3 (DHA and EPA) on the development of advanced AMD."This macular degeneration clinical trial is no longer recruiting new participants but it is ongoing. Enrollment concluded in June 2008 and participants will be followed between five and six years. To learn more about this macular degeneration research click here:
AREDS 2
Go from Macular Degeneration Clinical Trials to Macular Degeneration
Would you like to be updated on the latest: 
√ Clinical Trials? √ Prevention of Macular Degeneration? √ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News.
|
